Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $41,005 | 21 | 78.1% |
| Food and Beverage | $10,096 | 180 | 19.2% |
| Travel and Lodging | $1,174 | 9 | 2.2% |
| Consulting Fee | $167.00 | 1 | 0.3% |
| Gift | $53.66 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $18,947 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12,757 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $11,619 | 11 | $0 (2019) |
| BIOTRONIK INC. | $2,548 | 37 | $0 (2024) |
| Kestra Medical Technology Services, Inc. | $1,865 | 20 | $0 (2024) |
| Abbott Laboratories | $920.01 | 19 | $0 (2022) |
| Medtronic, Inc. | $454.10 | 6 | $0 (2024) |
| Amgen Inc. | $395.35 | 13 | $0 (2024) |
| Canon Medical Systems USA, Inc. | $314.34 | 2 | $0 (2018) |
| ShockWave Medical, Inc | $313.51 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,152 | 75 | Kestra Medical Technology Services, Inc. ($1,653) |
| 2023 | $1,588 | 31 | BIOTRONIK INC. ($554.30) |
| 2022 | $680.51 | 14 | BIOTRONIK INC. ($565.39) |
| 2021 | $50.41 | 4 | Abbott Laboratories ($24.16) |
| 2020 | $2,214 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($2,080) |
| 2019 | $19,654 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($10,400) |
| 2018 | $21,287 | 46 | PFIZER INC. ($16,632) |
| 2017 | $2,869 | 17 | PFIZER INC. ($2,278) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Genetic Disease | ||||||
| 12/06/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $138.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $44.45 | General |
| Category: Genetic Disease | ||||||
| 12/04/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2024 | ABIOMED | Impella (Device) | Gift | In-kind items and services | $53.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Cardiology | ||||||
| 11/22/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $141.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: DIABETES | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/01/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/28/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $7.28 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $96.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $269.58 | General |
| Category: Cardiology | ||||||
| 09/13/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: Cardiology | ||||||
| 08/09/2024 | BIOTRONIK INC. | BIOMONITOR (Device) | Food and Beverage | In-kind items and services | $72.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $165.20 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 3,452 | 4,471 | $1.1M | $266,406 |
| 2022 | 36 | 4,428 | 5,885 | $1.5M | $366,913 |
| 2021 | 42 | 4,831 | 6,894 | $1.7M | $422,836 |
| 2020 | 36 | 4,403 | 6,276 | $1.3M | $316,179 |
All Medicare Procedures & Services
164 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 663 | 988 | $313,244 | $87,181 | 27.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 175 | 509 | $108,928 | $31,678 | 29.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 343 | 352 | $68,050 | $16,689 | 24.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 57 | 58 | $82,308 | $13,181 | 16.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 88 | 99 | $42,615 | $12,715 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 140 | 161 | $29,100 | $10,937 | 37.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 98 | 106 | $41,834 | $10,766 | 25.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 163 | 163 | $39,105 | $8,656 | 22.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 24 | 24 | $26,674 | $7,690 | 28.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 49 | 49 | $30,723 | $7,526 | 24.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 54 | $32,440 | $7,285 | 22.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 456 | 583 | $31,399 | $6,094 | 19.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 62 | $19,671 | $5,783 | 29.4% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $18,315 | $4,505 | 24.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 31 | 31 | $15,916 | $4,490 | 28.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 38 | 38 | $18,432 | $4,135 | 22.4% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 42 | 43 | $14,159 | $3,389 | 23.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 22 | 88 | $34,664 | $3,247 | 9.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 11 | 22 | $3,888 | $3,048 | 78.4% |
| 75574 | Ct scan of blood vessels and grafts of heart with contrast | Facility | 2023 | 33 | 33 | $72,402 | $2,709 | 3.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 12 | 24 | $10,920 | $2,119 | 19.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 177 | 177 | $8,110 | $1,729 | 21.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 88 | 88 | $5,938 | $1,307 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 17 | $5,508 | $1,307 | 23.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 187 | 217 | $11,718 | $1,301 | 11.1% |
About Dr. Arnold Einhorn, MD
Dr. Arnold Einhorn, MD is a Cardiovascular Disease healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972564482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Arnold Einhorn, MD has received a total of $52,496 in payments from pharmaceutical and medical device companies, with $4,152 received in 2024. These payments were reported across 212 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($41,005).
As a Medicare-enrolled provider, Einhorn has provided services to 17,114 Medicare beneficiaries, totaling 23,526 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 164 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Orlando, FL
- Active Since 04/01/2006
- Last Updated 11/22/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1972564482
Products in Payments
- CHANTIX (Drug) $18,784
- PRADAXA (Drug) $12,717
- LEXISCAN (Drug) $5,394
- Assure WCD (Device) $1,865
- BIOMONITOR (Device) $1,675
- Repatha (Biological) $348.72
- MAGNETOM Terra 7T MRI Scanner (Device) $279.05
- COREVALVE EVOLUT R (Device) $253.14
- Pacemakers (Device) $220.34
- AMVIA EDGE (Device) $218.62
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $183.12
- Fortify Assura, Ellipse ICD (Device) $159.54
- CRT-Ds (Device) $158.56
- Confirm Rx (Device) $158.01
- NEXLETOL (Drug) $157.58
- BodyGuardian (Device) $155.86
- XARELTO (Drug) $154.22
- Impella (Device) $150.60
- ELIQUIS (Drug) $140.66
- VENASEAL (Device) $139.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Orlando
Naveen Bellam, M.d, M.D
Cardiovascular Disease — Payments: $315,652
Dr. Bruce Stein, Md, MD
Cardiovascular Disease — Payments: $291,287
Carlos Zamora, M.d, M.D
Cardiovascular Disease — Payments: $215,909
Nirav Raval, Md, MD
Cardiovascular Disease — Payments: $171,358
James Tarver, M.d, M.D
Cardiovascular Disease — Payments: $133,743
Aurelio Duran, M.d, M.D
Cardiovascular Disease — Payments: $110,928